Results 11 to 20 of about 1,206,341 (327)

Interferon Gamma in Leishmaniasis [PDF]

open access: yesFrontiers in Immunology, 2013
Leishmaniasis is a complex disease that is caused by parasites of the Leishmania genus. Leishmania are further classified into several complexes, each of which can engage in distinct interactions with mammalian hosts resulting in differing disease ...
Peter Kima, Lynn Soong, Soong Lynn
exaly   +6 more sources

Interferon-Gamma-Mediated Osteoimmunology [PDF]

open access: yesFrontiers in Immunology, 2018
Osteoimmunology is the interdiscipline that focuses on the relationship between the skeletal and immune systems. They are interconnected by shared signal pathways and cytokines.
Xijie Yu, Li Tian, Yu Xijie
exaly   +6 more sources

The Interferon-Gamma Paradox in Cancer [PDF]

open access: yesJournal of Interferon and Cytokine Research, 2019
Interferon-gamma (IFNG) has long been implicated as a central orchestrator of antitumor immune responses in the elimination stage of the immunoediting paradigm.
M Raza Zaidi
exaly   +4 more sources

The role of interferon-gamma and interferon-gamma receptor in tuberculosis and nontuberculous mycobacterial infections

open access: yesInternational Journal of Mycobacteriology, 2021
Mycobacterium tuberculosis (Mtb) and nontuberculous mycobacteria (NTM) remain the leading causes of lung disease and mortality worldwide. Interferon-gamma (IFN-γ) and its receptor (IFN-γR) play a key role in mediating immunity against Mtb and NTM.
Jalaledin Ghanavi   +3 more
doaj   +4 more sources

Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion

open access: yesFrontiers in Immunology, 2018
Interferon-gamma (IFN-γ) is a pleiotropic molecule with associated antiproliferative, pro-apoptotic and antitumor mechanisms. This effector cytokine, often considered as a major effector of immunity, has been used in the treatment of several diseases ...
Karine Serre   +2 more
exaly   +2 more sources

Interferon gamma in cancer immunotherapy

open access: yesCancer Medicine, 2018
Immune system can recognize self vs transformed self. That is why cancer immunotherapy achieves notable benefits in a wide variety of cancers. Recently, several papers reported that immune checkpoint blockade therapy led to upregulation of IFNγ and in ...
Ling Ni, Jian Lu
doaj   +2 more sources

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

open access: yesCell Reports, 2017
PD-L1 and PD-L2 are ligands for the PD-1 immune inhibiting checkpoint that can be induced in tumors by interferon exposure, leading to immune evasion. This process is important for immunotherapy based on PD-1 blockade.
Angel Garcia-Diaz   +18 more
doaj   +2 more sources

Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence

open access: yesPulmonary Medicine, 2013
A profusion of articles have been published on the accuracy and uses of interferon-gamma releasing assays. Here we review the clinical applications, advantages, and limitations of the tuberculin skin test and interferon-gamma release assays and provide ...
A. Trajman, R. E. Steffen, D. Menzies
doaj   +2 more sources

Immune hyperactivity in hemodialysis patients is associated with interferon gamma-induced trained immunity. [PDF]

open access: goldiScience
Jonkman I   +12 more
europepmc   +2 more sources

Dapagliflozin confers protection against ferroptosis in cardiomyocyte via the inhibition of interferon-gamma pathway. [PDF]

open access: hybridMol Biol Rep
Menaldi RR   +7 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy